# A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

> **NCT07351058** · PHASE3 · RECRUITING · sponsor: **Hoffmann-La Roche** · enrollment: 1600 (estimated)

## Conditions studied

- Obesity or Overweight
- Type 2 Diabetes Mellitus

## Interventions

- **COMBINATION_PRODUCT:** Placebo
- **COMBINATION_PRODUCT:** Enicepatide

## Key facts

- **NCT ID:** NCT07351058
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2028-08-07
- **Final completion:** 2028-08-07
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07351058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07351058, "A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07351058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*